KERX
Keryx Biopharmaceuticals Inc
KERX
KERX
Delisted
KERX was delisted on the 12th of December, 2018.
132 hedge funds and large institutions have $563M invested in Keryx Biopharmaceuticals Inc in 2017 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 49 increasing their positions, 34 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
132
Holders Change
+6
Holders Change %
+4.76%
% of All Funds
3.3%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
16
Increased
49
Reduced
34
Closed
9
Calls
$3.44M
Puts
$5.14M
Net Calls
-$1.71M
Net Calls Change
-$3.23M
Top Buyers
| 1 |
Russell Investments Group
London,
United Kingdom
|
+$4.72M |
| 2 |
BlackRock
New York
|
+$4.12M |
| 3 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$3.47M |
| 4 |
State Street
Boston,
Massachusetts
|
+$3.39M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.6M |
Top Sellers
| 1 |
CCM
Consonance Capital Management
New York
|
-$12.6M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$10.3M |
| 3 |
Millennium Management
New York
|
-$2.92M |
| 4 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
-$1.6M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$936K |
